chrisvoncsefalvay/vaers-outcomes huggingface dataset:
SM developed and urticarial rash (both arms, back and torso and legs) 24-48 hrs after a COVID-19 second vaccine. The vaccine was administration last Monday and developed an generalized rash and itch since yesterday. No difficulty breathing associated symptoms to this vaccine administration. Referred to PMC for Tx. Routine medical care. OTC TX recommended to the member.
Extreme diarrhea, cramping, muscle weakness and fatigue within 12 hrs. of vaccination.
body rash/Rash was noted by caller on her right and left arms, back of her legs, entire abdomen and back/full body rash; This is a spontaneous report from a contactable consumer(patient) via medical information team. A 33-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: Unknown) via an unspecified route of administration on 25Jan2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On unspecified date on Jan2021 at 14:00 about 48hrs after vaccination, the patient got body rash, her right and left arms, back of her legs, entire abdomen and back was full of body rash. The outcome of the event was unknown.  Information about lot/batch number has been requested.  Follow-up (16Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
About 40 hours after my second Pfizer Covid-19 vaccine, I developed ringing in both ears.  It hasn't stopped since it started almost a year ago.  I was on a daily birth control (Junel Fe) but otherwise healthy and no allergies or issues with any other medications or vaccines.  I was evaluated by my PCP and then an ENT specialist, and they didn't have an explanation for the ringing.
Information has been received from a registered nurse concerning a patient who between 09-MAR-2010 and 18-MAR-2010 received a 0.5 ml IM dose of PNEUMOVAX 23 (lot# 664476/1190Y). Between 09-MAR-2010 and 18-MAR-2010, 24 hours after vaccination with PNEUMOVAX 23, the patient developed cellulitis reaction on their arms. The patient sought unspecified medical attention. At the time of the report, the outcome of the patient was unknown. This is one of several reports received from the same source. A standard lot check investigation has been finalized. All in-process quality checks for the lot number 664476/1190Y were satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. The nurse contacted during telephone follow-up could not supply the following information: patient names, dates of birth, dates of vaccination, dates of events and recovery status. Additional information has been requested.
Patient arrived at ER with complaints of CPR in progress. Per EMS, patient became short of breath while performing yard work on 1/26/2021. At arrival, patient was in fine v fib with a total of 6 shocks delivered along with 300 mg amiodarone followed by 150 mg amiodarone, 1 amp epinephrine and 2 epinephrine drips adminstered en route to ED.  CPR initiated at 1755 and EMS reports asystole at 1829.  TOD 1909 pronounced by ED DO Dx: Cardiac arrest
Presented to ER 12/23/2020 with Lightheadedness, chills, nausea, vomiting, rash. Iv fluids and antiemetics administered, pt reported feeling better. RX for Medrol Dosepak given.
I had minimal symptoms after my first dose, some injection site pain, very mild, for a day or two which then completely resolved.  At day 9 post injection, my arm at the injection site did become itchy and when I looked at the area, there was about a 2-1/2 circle of mild redness around the injection site.  This persisted for about 24 hours along with the mild itching and mild soreness.  I spoke to a coworker who received her vaccine first dose around the time I did and she had a similar reaction.  Again, very mild but definitely additional redness, itching, and mild soreness at the injection site 9 days post the first dose after my initial symptoms had completely resolved.  This required no real treatment.  I iced it that evening, and it only lasted about 24 hours but it was surprising as the initial symptoms had completely resolved.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 71-year-old female patient who received Shingrix for prophylaxis. Previously administered products included Zostavax (dose received on an unknown date). On 26th July 2018, the patient received the 1st dose of Shingrix (intramuscular). On 26th July 2018, less than a day after receiving Shingrix, the patient experienced pain in arm, arthritis of neck, erythema of extremities, neck pain and shoulder pain. On an unknown date, the patient experienced vibratory sense increased, joint range of motion decreased and tingling sensation. On an unknown date, the outcome of the pain in arm, vibratory sense increased, arthritis of neck, joint range of motion decreased and tingling sensation were not recovered/not resolved and the outcome of the erythema of extremities, neck pain and shoulder pain were unknown. It was unknown if the reporter considered the pain in arm, vibratory sense increased, arthritis of neck, joint range of motion decreased, tingling sensation, erythema of extremities, neck pain and shoulder pain to be related to Shingrix. Additional information was received as follows: The patient received Shingrix on the right arm. The patient stated that later that evening of the vaccination day, she experienced the pain and the redness in her right arm and the pain traveled to the right side of her neck and to the right shoulder. The patient stated that she had the tingling sensation in her neck (right side) and in right shoulder that felt like ants were crawling in her neck and shoulder (latency of less than 2 months). The patient stated that she had got the vibration sensation for every 30 minutes in the neck and stated that the vibration sensations started some time later than the same day. The patient stated that she could not turn her neck to the right side. The patient went to visit her physician 1 week before the reporting day and had X-ray. The physician informed to the patient that she had a little arthritis in the neck. The patient stated that she did not have arthritis or pain before she received Shingrix. The patient stated that her physician advised her not to receive the 2nd dose of Shingrix. The patient also reported this to two of the pharmacist at the pharmacy in which she received Shingrix. The contact details of the physician were provided.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Feb-2022 at 17:36:48; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Feb-2022 at 17:36:48; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Feb-2022 at 17:36:48) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Feb-2022 at 17:36:48) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2022 at 5:36 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Feb-2022 at 5:36 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Feb-2022 at 17:36:48). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Feb-2022 at 17:36:48). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Feb-2022 at 17:36:48) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Feb-2022 at 17:36:48) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by reporter. The patient's ethnicity was reported. It was unknown if the patient had acute illness at the time of vaccination and up to one month before. It was unknown if the patient had chronic or long lasting health conditions. Concomitant product use was not provided by the reporter. It was unknown if the patient received any prescriptions, over the counter medications, dietary supplements or herbal remedies at the time of vaccination and or at the time of adverse event. It was unknown if the patient received other vaccines given on the same day and it was also unknown if the patient received other vaccines within one month prior to any dose of Moderna vaccine. It was unknown if the patient experienced any adverse events or not. The patient received Moderna vaccine past its 30 day of expiry date. It went into 2-to-8-degree Celsius thaw state on or about 24-Dec-2021. This vaccine was administered up until its manufacturing expiry date of 04-Apr-2022.  No treatment information was provided.   This case was linked to MOD-2022-542869 (Patient Link).
Bump around collar bone; hurting on arm andunderneath arm; hurting on arm andunderneath arm; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: er8732), via an unspecified route of administration in the left arm on 25Mar2021 at 13:45 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroid. Concomitant medications included levothyroxine sodium (SYNTHROID) for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: en6199), via an unspecified route of administration in the left arm on 03Mar2021 at 15:30 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 26Mar2021 at 13:45, the patient had experienced a bump around the collar bone that moved when she moved and stuck out in a certain position. The patient also experienced hurting on arm and underneath arm on 26Mar2021 at 13:45. The patient did not receive any therapeutic measures for the reported events. Adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events bump around collar bone, hurting on arm and underneath arm was not resolved at the time of report.  No follow-up attempts are needed. No further information is expected.
I received my 2nd dose of the moderna vaccine on 1/24/21. On 1/25/21 at approx 2am I had tremmors, feeling of intense cold, headache, body pain, fatigue. That lasted until approx 0300am 1/26/21. I slept most of the day 1/25 except for taking kid to school and monitoring another at home. I had read the side effects and I felt as though things were subsiding  on 1/26 but I was still weak with body pain. I was not 100%. I was home alone with 2 kids (wife out of town). 1/25 I had a cough and was short of breath but didn't think much of it. The cough persisted. On 1/27/21 I was still short of breath. I went to a nearby fire station and had them put me on a lifepack. I was in atrial fibrillation. I could not do anything because my wife wasn't due back until 3pm. At 3PM she walked in and I walked out and drove myself to Hospital. I was diagnosed with A-Fib w/ RVR. I was in A-fib until I was cardioverted on 2/1/21 and was given a cryo-ablation.
Arthalgia, Diarrhea, Nausea, Vomiting and Chills, erythema.
Since getting the vaccine, I have headaches and a constant ringing in my right side of my face that causes discomfort and pain. On the right side of my face, I also feel pain and my face feels numb.
Patient received moderna vaccine on 2/23/21, 3/24/21, and 12/13/21. Presented to ER on 1/23/22. presented with hemoglobin of 5.21 hypotension.  Patient was also COVID test positive on 01/23.  He was recently hospitalized for GI bleed and had extensive workup done at that time.  Patient admitted due to GI bleed. No COVID19 treatments. Discharged on 1/30/22
Severe pain and leg cramping in both legs from foot to upper thigh; Severe pain and leg cramping in both legs from foot to upper thigh; I was screaming in pain; This is a spontaneous report from a contactable consumer, the patient. A 75-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 25Feb2021 at 10:00 (at the age of 75-year-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure, depression, attention deficit hyperactivity disorder (ADD), hernia, low thyroid and high cholesterol. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 26Feb2021 at 02:00, in the early morning, the patient experienced severe pain and leg cramping in both legs from foot to upper thigh. The patient had not experienced anything like this and the pain lasted over an hour. The patient was screaming in pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe pain (in both legs from foot to upper thigh) and screaming in pain was recovered on 26Feb2021 whereas the event leg cramping in both legs from foot to upper thigh was recovered an unknown date in Feb2021.   No follow-up attempts are needed. No further information is expected.
Vaccine given at noon on 7/16/07 and pt reports onset of arm pain and myalgias that evening. Over the next 2 days, she developed fever up to 101, leg cramps and increasing arm pain. Seen at an urgent care clinic and diagnosed with cellulitis, given antibiotics and came here the next day. Concentric erythema with superficial induration at injection site but no streaking seen. Started on Ibuprofen 800mg q8h. 24 hours later decreased pain and slight decrease in erythema. Patient failed to return for subsequent follow-up as directed.
Pt got vaccine in AM.  Dad called around 15:00, stated pt was covered in hives, lips pink, no respiratory distress.  Told to give Benadryl and go to local ER.
Warm to touch at the injection site; Raised bump at the injection site; A three inch rash at the injection site; Redness at the injection site; Itchy at the injection site; This spontaneous case was received on 18-Sep-2020 from other non-health professional via Agency (reference number: SEQW20-01953) and concerned a patient of unknown age and gender.  The patient's medical history and concomitant medications were not reported.   On an unspecified date in 2020, the patient was vaccinated with Flucelvax QIV (influenza vaccine, subunit influenza virus vaccine polyvalent, route of administration: intramuscular, dose: full dose as reported, anatomical location: not reported) for influenza prophylaxis. The batch number reported was 283849, expiry date: 30-Jun-2021. The product was stored in refrigeration and no temperature excursions occurred with the vaccines. The vaccine was administered by nurse practitioner without any leakage of vaccine.   On an unspecified date in 2020, during an injection of Flucelvax QIV, the patient developed a raised bump and a three-inch rash around the injection site. In addition, the patient experienced adverse reactions of redness, warm to touch, itchy and raised at the injection site. There had been nothing in regards of treatment administered. The reactions lasted longer than expected.   On an unspecified date in 2020, the patient recovered from all events.   The reporter did not provide a causality assessment.   The reporter assessed the case as non-serious.  This case is linked to cases 202004573, 202004596, 202004597, 202004598, 202004599, 202004601, 202004602, 202004603, 202004604, 202004605 and 202004606 (the same reporter).  Additional information received on 25-Sep-2020 from other health professional: Two reporters were provided, and all events changed from medically confirmed 'NO' to 'YES'. Route of administration was provided. The events 'vaccination site redness', 'vaccination site warmth' and 'vaccination site pruritus' added. The outcome of the events 'vaccination site lump' and 'vaccination site rash' changed from 'unknown' to 'resolved'. Narrative amended accordingly.  Additional information received on 06-Jan-20201from other health professional: One additional reporter and reference number added. Narrative was not amended.  Company comment: The patient developed vaccination site mass, vaccination site rash, vaccination site pruritus, vaccination site erythema and vaccination site warmth after receiving the suspect product, Flucelvax QIV. Chronology is plausible. No information regarding concomitant medications and medical history was provided. Based on this information, causal relationship for all events is assessed as possibly related.; Sender's Comments: The patient developed vaccination site mass, vaccination site rash, vaccination site pruritus, vaccination site erythema and vaccination site warmth after receiving the suspect product, Flucelvax QIV. Chronology is plausible. No information regarding concomitant medications and medical history was provided. Based on this information, causal relationship for all events is assessed as possibly related.
See attached sheet. April 20, 2012 Vaccine administered at pharmacy. April 27, 2012 Began noticing a rash on three places on my scalp that was itching and burning. After attempting to treat it with Neosporin Cream for approximately one week I called the doctor and was told the nurse could look at the spots on May 9th. May 9th 2012 Two nurses at the clinic looked at the red spots and recommended I apply an 'anti itch cream' for the next week and then call for an appointment if the spots did not clear up. I informed the nurses that I have received the Zoster vaccine on April 20 and ask if that could be the cause. I purchased 2% Diphenhydramine Hydrochloride with .01% Zinc Acetate at the pharmacy and begin using the next day. May 17, 2012 Red spits had not improved. The skin at one of the spots would also peel and continues to do so. Doctor could not see me due to his schedule and my schedule for the next two weeks and I was told to continue using the anti itch cream and an appointment was made for June 5. I stopped using the cream on June 2. June 5, 2012 Doctor looked at the red rash spots that had not improved and I ask him if the Zoster Vaccine I had received could be causing the rash. He did not comment on the vaccine but told me not to use any shampoo on my hair, keep the sun off my head and just wash with regular water for the next two weeks. If the rash had not cleared up by then he would set me an appointment with a dermatologist. June 10, 2012 The rash had not improved so I stopped by pharmacy an ask immunization pharmacist what he thought about the rash reaction. He recommended that I complete a VAERS and report the adverse event since it could be caused by the ZOSTAVAX vaccine. June 12, 2012 The red rash has still not improved and the burning sensation and some itching remains. I took a picture of the spots on my scalp this date.
muscle pain; the same pain but its intensity and location has changed; he was still in pain its joint; the pain travelled from his shoulder to his elbow to his hand primarily the thumb and then the upper part of the forearm the outside of the forearm; This is a spontaneous report from a contactable consumer. A 69-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE ; Lot Number: ER2613; Expiration Date: Jul2021), via an unspecified route of administration, administered in Arm Left on 18Mar2021 at unknown dose number single for covid-19 immunization. Medical history included asthma, coronary artery disease, osteoarthritis. The patient's concomitant medications included supplements. In mar2021, patient experienced muscle pain, had pain that travelled from his shoulder to his elbow to his hand primarily the thumb and then the upper part of the forearm the outside of the forearm not the inner part that was affected the most and had pain in his joint. The reaction has progressed and things has changed a bit, there was still the same pain but its intensity and location has changed in Mar2021. Patient took Ibuprofen, acetaminophen and Benadryl for the events. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
5-6 genital warts developed on the patient's testicles.  He states that they were the size of a pencil eraser.  Occasional burning sensation, no swelling, some itching.
right foot Numbness; Severe fatigue; Numbness left arm and right hand.; Electric shock sensations up arms and legs; headache; cognitive issues; This is a spontaneous report received from a contactable consumer (patient). A 46-year-old female non pregnant patient reported for herself that patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EM6200), via an unspecified route of administration, administered in right arm on 29Mar2021 at 08:00 AM (vaccinated at the age of 46 years) as DOSE 1, SINGLE and received second dose via an unspecified route of administration, administered in left arm on 19Apr2021 at 08:00 AM (Batch/Lot Number: EN6955) as DOSE 2, SINGLE for covid-19 immunisation. The patient was not pregnancy at time of vaccination. The patient medical history was not reported. Concomitant medications included amlodipine, estrogens conjugated and citropram; all were taken for an unspecified indication, start and stop date were not reported and the patient received within 2 weeks of vaccination. Not received any other medications in four weeks. The patient was not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Mar2021, the patient experienced numbness left arm and right hand. Electric shock sensations up arms and legs right foot Numbness headache severe fatigue cognitive issues. Adverse events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events with unknown medication as per neurologist referral. The patient did not had covid prior vaccination and did not got covid tested post vaccination. The report was non serious. Outcome of the events was unknown.
A week after my 1st shot, my knees feel incredibly stiff and achy. it hurt to walk up steps and had to do it one step at a time. I could not squat and rise from squatted position due to inability to push off with left leg/knee. Intensity varied day to day but was always an issue right up to a few days before 2nd shot dose when symptoms appeared to be dissipating. After my 2nd shot, symptoms were still continuing to dissipate for about a week. After a week, all symptoms returned in full force and have still not lessened a full 6 weeks after my 2nd dose.